1433362-88-9

Upstream product

• 3282-30-2 pivaloyl chloride 
• 133992-53-7 5-amino-1-[(4-methoxyphenyl)methyl]-1,2,3-triazole-4-carboxamide 
• 1433363-06-4 1-(4-methoxybenzyl)-5-pivalamido-1H-1,2,3-triazole-4-carboxamide 
• 1433363-08-6 N-(4-cyano-1-(4-methoxybenzyl)-1H-1,2,3-triazol-5-yl)pivalamide 
• 824-94-2 p-methoxybenzyl chloride 
• 70978-37-9 1-(azidomethyl)-4-methoxybenzene 

Downstream Products

• 1433359-02-4 4-(5-tert-butyl-3-(4-methoxybenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)morpholine 
• 1433359-08-0 5-tert-butyl-3-(2-chloro-4-fluoro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine 
• 1438465-56-5 5-tert-butyl-2-(2-chloro-benzyl)-7-(morpholin-4-yl)-2H-[1,2,3]triazolo[4,5-d]pyrimidine 
• 1433363-10-0 5-tert-butyl-7-chloro-3-(4-methoxy benzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine 

Relevant academic research and scientific papers

[1, 2, 3] TRIAZOLO [4, 5 -D] PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2

The invention relates to a compound of formula (I), wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament as agonists of the cannabinoid receptor 2.

[1, 2, 3]TRIAZOLO [4, 5 -D] PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2 AGONISTS

The invention relates to a compound of formula (I) wherein A and R to R 3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A and R1 to R3 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.